Mobile Acoustic Startle Reflex-monitoring System (MARS)
1 other identifier
interventional
55
1 country
1
Brief Summary
This is a pilot study of 55 adult male veterans with PTSD. The study will test a new mobile application "app" that can be run on an iPhone10. The app, which is called the Mobile Acoustic startle Reflex-monitoring System (a.k.a., MARS), will be used to measure participant's acoustic startle in sitting or standing postures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 30, 2019
CompletedFirst Posted
Study publicly available on registry
October 3, 2019
CompletedStudy Start
First participant enrolled
November 28, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2021
CompletedAugust 27, 2021
August 1, 2021
6 months
September 30, 2019
August 25, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Acoustic Startle Response (speed)
The acoustic startle response is the physiological measurement of eye-blink reflex following a sound. In the present protocol, various intensities of sound will be played using specialized equipment that plays sound through noise-cancelling earphones. The acoustic startle measure will be obtained using an "App" on an Apple iPhone 10. The primary startle response outcome is the time in seconds (typically milliseconds) between the playing of the sound, and the individual's eyeblink.
1 year after initiation of enrollment
Secondary Outcomes (1)
Acoustic Startle Response (amplitude)
1 year after the initiation of enrollment
Other Outcomes (1)
Relationship between acoustic startle reflex and PTSD severity
1 year after the initiation of enrollment
Study Arms (2)
Sitting
EXPERIMENTALSubjects will undergo acoustic startle testing in the sitting position.
Standing
EXPERIMENTALSubjects will undergo acoustic startle testing in the standing position.
Interventions
Acoustic startle testing
Eligibility Criteria
You may qualify if:
- diagnosis of PTSD
You may not qualify if:
- positive drug or alcohol screen
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Johns Hopkins Universitylead
- School of Biomedical Sciences, University of Otago, Dunedin, New Zealandcollaborator
- DigiTheronixcollaborator
Study Sites (1)
Johns Hopkins Bayview Medical Center
Baltimore, Maryland, 21224, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Una McCann, MD
Johns Hopkins University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- The study psychiatrist will be blind to MARS results at the time of the psychiatric interview that will confirm PTSD diagnosis and PTSD severity.
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 30, 2019
First Posted
October 3, 2019
Study Start
November 28, 2020
Primary Completion
June 1, 2021
Study Completion
June 1, 2021
Last Updated
August 27, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- Data will be available to investigators in New Zealand at the time of data analyses, approximately one year after the study has begun.
- Access Criteria
- Only Dr. Yusuf Cakmak and data analyst (who will conduct the data analyses) will have access to the data. They will have a copy of the data which will be saved on a secure server.
Data analyses will be conducted by study investigators in New Zealand. Both sites (Baltimore and New Zealand) will have access to all study data.